¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Receptor, Nerve Growth Factor"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® sensory nerve ÇÑ±Û °¨°¢½Å°æ
¼³¸í   
  °¨°¢¼¼Æ÷°¡ ¹ÞÀº ÀÚ±ØÀ» ÁßÃ߽Ű濡 Àü´ÞÇϴ ½Å°æ. ´«À̳ª ÇǺΠµî¿¡ Àִ °¨°¢±â°¡ ¿ÜºÎ·ÎºÎÅÍ ÀÚ±ØÀ» ¹ÞÀ¸¸é °¨°¢½Å°æÀ» °ÅÃĠô¼ö¿Í ´ë³ú°ÑÁú±îÁö °¨°¢ÀÌ Àü´ÞµÈ´Ù. À̿͠°°ÀÌ ¿ÜºÎ·ÎºÎÅÍ ³»ºÎ¸¦ ÇâÇØ Àü´ÞµÇ´Â °¨°¢½Å°æÀº ±¸½É¼º ½Å°æ°èÅëÀ̸ç, ¿ø½É¼º ¿îµ¿½Å°æ°èÅë ¹× ÀÚÀ²½Å°æ°èÅë¿¡ ÇÊÀûÇϴ ¸»ÃʽŰæÀÇ ÇϳªÀÌ´Ù. ÀÌ °¨°¢½Å°æ¿¡´Â Èİ¢½Å°æ(³ú½Å°æ¥°)-½Ã°¢½Å°æ(³ú½Å°æ¥±)-´«µ¹¸²½Å°æ(³ú½Å°æ¥²)-»ïÂ÷½Å°æ(³ú½Å°æ¥´)-¾ó±¼½Å°æ(³ú½Å°æ¥¶)-û°¢½Å°æ(³ú½Å°æ¥·)-ÇôÀενŰæ(³ú½Å°æ¥¸)-¹ÌÁֽŰæ(³ú½Å°æ¥¹) ¹× Ã´¼ö½Å°æÀÌ ÀÖ´Ù. °¨°¢½Å°æ Áß ¹ÌÁֽŰæÀ» Á¦¿ÜÇϸ頸ðµÎ µÎºÎ¿¡ ºÐÆ÷µÇ¾î ÀÖ°í, Èİ¢½Å°æ-½Ã°¢½Å°æ-û°¢½Å°æÀÇ ¼¼°¡Áö´Â Æ¯È÷ ºÐÈ­µÈ °¨°¢»óÇǸ¦ Áö¹èÇÑ´Ù. ÇôÀενŰæÀº ¹Ì°¢ÀÇ ¸»´ÜÀåÄ¡¿Í ±× ¹ÛÀÇ ºÎºÐ¿¡ ¿¬°áµÇ°í ¹ÌÁֽŰæÀº Èä°­°ú º¹°­ÀÇ ±â°ü¿¡ ºÐÆ÷µÇ¾î ±¸½É¼º Ãæ°ÝÀ» ÁßÃß¿¡ Àü´ÞÇϸ砻ïÂ÷½Å°æÀº Ã´¼öÀÇ °¢ ¸¶µð¿¡ Àִ ½Å°æ¿¡ ÇØ´çÇÏ¿©(¸Ó¸®ÀÇ ÇǺÎ-Á¡¸· µîÀǠǥ¸é°¨°¢°ú ½ÉºÎ°¨°¢À» °üÀåÇÑ´Ù. Ã´¼öÀÇ °¨°¢½Å°æ°èÅë¿¡µµ ÇǺο͠½ÉºÎ, ³»ÀåÀÇ ºÐÆ÷¿¡ µû¸¥ ±¸º°ÀÌ ÀÖ´Ù. 
¿µ¹® cranial nerve ÇÑ±Û ³ú½Å°æ
¼³¸í   
  ´ëºÎºÐÀÇ ½Å°æÀº Ã´¼ö¸¦ ÅëÇØ¼­ ³ª°£´Ù. ±×·¯³ª ¸î¸îÀÇ ½Å°æÀº ³ú¿¡¼­ ¹Ù·Î ³ª°£´Ù. ÀÌ·¸°Ô ³ú¿¡¼­ ¹Ù·Î ³ª°¡´Â ½Å°æÀ» ³ú½Å°æÀ̶ó°í ÇÑ´Ù. ÀÌ ³ú½Å°æÀº 12°³·Î ¸ðµÎ ´ëĪÀûÀΠ½ÖÀ¸·Î Á¸ÀçÇÑ´Ù. ÀÌ ³ú½Å°æÀº ÁַΠƯ¼ö°¨°¢(½Ã°¢, Ã»°¢, Èİ¢, ¹Ì°¢)°ú ¾ó±¼ µîÀÇ ÀϺΠ±ÙÀ°À» Áö¹èÇÏ°í ½ÉÀåÀ̳ª ³»ÀåÀÇ Áö¹èµµ ÀϺΠ´ã´çÇϰí ÀÖ´Ù. 12°³ÀÇ ½Å°æÀº °¢°¢ ´ÙÀ½°ú °°Àº À̸§°ú °íÀ¯¹øÈ£¸¦ °¡Áö°í ÀÖ´Ù.
  
  -Èİ¢½Å°æ(olfactory nerve)£­Èİ¢À» ´ã´çÇϴ ½Å°æ,
  
  -½Ã°¢½Å°æ(optic nerve)£­½Ã°¢À» ´ã´çÇϴ ½Å°æ.
  
  -´«µ¹¸²½Å°æ(oculomotor nerve)£­¿îµ¿À» ´ã´çÇϴ ½Å°æ,
  
  -µµ¸£·¡½Å°æ(trochlear nerve)£­´«ÀÇ ¿îµ¿À» ´ã´çÇϴ ½Å°æ.
  
  -»ïÂ÷½Å°æ(trigeminal nerve)£­3°³ÀÇ °¡Áö¸¦ °¡Áö´Â ½Å°æÀ¸·Î ¾ó±¼ÀÇ °¨°¢°ú ¾Ã±â¸¦ À§ÇÑ ±ÙÀ°À» ¿òÁ÷À̴ ¿ªÇÒÀ» ÇÑ´Ù.
  
  -°¡µ¹¸²½Å°æ(abducent nerve)£­´«ÀÇ ¿îµ¿À» ´ã´çÇϴ ½Å°æ.
  
  -¾ó±¼½Å°æ(facial nerve)£­¾ó±¼ ±ÙÀ°ÀÇ ¿îµ¿À» ´ã´çÇϴ ½Å°æ. Áï ¾ó±¼ÀÌ ¿©·¯ °¡Áö Ç¥Á¤À» ³»´Â °ÍÀº ÀÌ ½Å°æÀÇ ÀÛ¿ëÀÌ´Ù. ±×¸®°í ÇôÀÇ ¾ÕºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇϴ ¿ªÇÒµµ ÇÑ´Ù.
  
  -¾È¶ã´ÞÆØÀ̽Űæ(vestibulocochlear nerve)£­¾È¶ã½Å°æ°ú ´ÞÆØÀ̽ŰæÀÇ 2°¡Áö ½Å°æÀ¸·Î ÀÌ·ç¾îÁø ½Å°æÀ¸·Î ¸ðµÎ ±Í¸¦ Áö¹èÇϴ ½Å°æÀÌ´Ù. ¾È¶ã½Å°æÀº ÆòÇü°¨°¢À» ´ã´çÇϴ °÷ÀΠ±ÍÀÇ ¾È¶ã¿¡¼­ ³ª¿À´Â ½Å°æÀ¸·Î ÆòÇü°¨°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ ÀüÇϴ ¿ªÇÒÀ» ÇÑ´Ù. ±×¸®°í ´ÞÆØÀ̽ŰæÀº Ã»°¢À» °¨ÁöÇϴ ´ÞÆØÀ̲®ÁúÀÇ ¸ð¾çÀ» °¡Áø ´ÞÆØÀÌ¿¡¼­ ±â¿øÇϴ ½Å°æÀ¸·Î Ã»°¢ÀÇ Á¤º¸¸¦ ³ú¿¡ Àü´ÞÇϴ ¿ªÇÒÀ» ÇÑ´Ù.
  
  -ÇôÀενŰæ(glossopharyngeal nerve)£­¸» ±×´ë·Î Çô¿Í Àεκο¡ ºÐÆ÷Çϴ ½Å°æÀ¸·Î ÀÎÈĺÎÀÇ ¿òÁ÷ÀÓ°ú ÇôÀÇ µÞºÎºÐÀÇ ¹Ì°¢À» ´ã´çÇÑ´Ù.
  
  -¹ÌÁֽŰæ(vagus nerve)£­¸» ±×´ë·Î ¾ÆÁÖ ¿©·¯ °÷¿¡ ºÐÆ÷ÇÏ¿© ºÐÆ÷¿µ¿ªÀÌ ¸ðÈ£ÇÑ ½Å°æÀÌ´Ù(vagus¶õ ¸ðÈ£ÇÑ À̶õ ¶æÀ» °¡Áø´Ù). ´ëºÎºÐÀÇ ³»Àå¿¡ ºÐÆ÷ÇÏ°í ¶Ç ½ÉÀå¿¡ ºÐÆ÷ÇÏ¿© ½ÉÀåÀÇ ¹Úµ¿¼ö¸¦ Á¶Á¤Çϴ ¿ªÇÒµµ ÇÑ´Ù.
  
  -´õºÎ½Å°æ(accessory nerve)£­µîÀÇ ±ÙÀ°°ú ¸ñÀÇ ±ÙÀ°ÀÇ ÀϺθ¦ Áö¹èÇϴ ½Å°æ.
  
  -Çô¹Ø½Å°æ(hypoglossal nerve)£­ÇôÀÇ ¿òÁ÷ÀÓÀ» °üÀåÇϴ ½Å°æ.
¿µ¹® afferent nerve ÇÑ±Û µé½Å°æ
¼³¸í   
  ¸öÀÇ Áß½ÉÀ¸·Î µé¾î¿À´Â ½Å°æ, Áï °¨°¢½Å°æÀ» ÁöĪÇϴ ¸»ÀÌ´Ù.
¿µ¹® peripheral nerve ÇÑ±Û ¸»ÃʽŰæ
¼³¸í   
  ÁßÃ߽Űæ°è¸¦ Á¦¿ÜÇÑ ³ª¸ÓÁö ¸ðµç½Å°æÀ» ¸»ÇÔ. ÁßÃ߽Űæ°è´Â ³ú¿Í Ã´¼ö¸¦ ¸»Çϸç, ±×¿Ü ³ª¸ÓÁö ½Å°æµé·Î½á ½ÇÁ¦ÀûÀ¸·Î °¢ ±â°üÀ̳ª »çÁö ¸»´Ü¿¡ ½Å°æÀÌ ºÐÆ÷Çϸç, ÀÚ±ØÀ» Àü´ÞÇϴ ÀÏÀ» Çϴ ½Å°æÀ» ¸ðµÎ ÅëÆ²¾î ¸»ÃʽŰæÀ̶ó ÇÑ´Ù. ³ú¿¡¼­ ¹Ù·Î ³ª¿Í ºÐÆ÷Çϴ ³ú½Å°æ°ú Ã´¼ö¿¡¼­ ±â½ÃÇϴ ô¼ö½Å°æµµ ¸ðµÎ ¸»ÃʽŰ濡 ÇØ´çÇÑ´Ù. ¶ÇÇÑ ¸»ÃʽŰ濡´Â °¢Á¾ ÀÚÀ²½Å°æÀ» ´ã´çÇϴ ±³°¨½Å°æ, ºÎ±³°¨½Å°æµµ Æ÷ÇԵȴÙ.
¿µ¹® vagus nerve ÇÑ±Û ¹ÌÁֽŰæ
¼³¸í   
  Á¦ 10³ú½Å°æ(³ú½Å°æÀº ³ú¿¡¼­ ±â½ÃÇÑ ¸»ÃʽŰæÀ¸·Î ¸ðµÎ 12°³°¡ ÀÖ´Ù)ÀÇ À̸§. ¿Ã¸®ºê¿Í ¾Æ·¡¼Ò³ú°¢(inferior cerebellopontine angle)»çÀÌ ¼û³ú ¿ÜÃø¿¡¼­ ³ª¿À´Â ¸¹Àº »Ñ¸®¼¶À¯·ÎºÎÅÍ ±â½ÃÇÏ¿© »óÈĵνŰæ, µÇµ¹ÀÌÈĵνŰæ, °æÁú¸·°¡Áö, ±Í¹ÙÄû°¡Áö, Àεΰ¡Áö, ½ÉÀå°¡Áö, ±â°üÁöÀÎÁö, À§°¡Áö, °£°¡Áö, º¹°­°¡Áö, ÄáÆÏ°¡Áö, ÀενŰæ¾ó±â(pharyngeal plexus), Æó½Å°æ¾ó±â(pulmonic plexus), ½Äµµ½Å°æ¾ó±â(esophageal plexus), Àü ¹× ÈÄ ¹ÌÁֽŰ氣(anterior & posterior vagal trunk)ÀÇ °¡Áö¸¦ ³½´Ù. ¹ÌÁֽŰæÀº ¸ñÁ¤¸Æ±¸¸Û(jugular foramen)À» ÅëÇØ ³»·Á°¡¼­ »óÇϽŰæÀý(superior & inferior ganglion)°ú ¿¬°áµÇ°í, ¸ñ ¹× °¡½¿¸¦ Áö³ª º¹ºÎ¿¡ µµ´ÞÇÑ´Ù. ±Í, Çô, ÀεÎ, Èĵο¡ °¨°¢¼ºÀ¸·Î, ÀεÎ, ÈĵΠ¹× ½Äµµ¿¡ ¿îµ¿¼ºÀ¸·Î, ±×¸®°í ÈäºÎ ¹× º¹ºÎÀÇ ±â°ü¿¡ ³»À屸½É¼ºÀ¸·Î ºÐÆ÷ÇÑ´Ù.
  
  ¹ÌÁֽŰæ
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bacterial growth rate
    ¼¼±ÕÁõ½Ä·ü
  • catch-up growth
    µû¶óÀâÀ̼ºÀå
  • exponential growth
    Áö¼öÁõ½Ä
  • exponential growth rate
    Áö¼öÁõ½Ä·ü, Áö¼ö¼ºÀå·ü
  • fetal growth retardation
    žƼºÀåÁö¿¬
  • growth
    1. ¼ºÀå, »ýÀå 2. Áõ½Ä, ¹ßÀ° 3. Áõ°¡
  • growth abnormality
    ¼ºÀåÀÌ»ó
  • growth acceleration
    ¼ºÀå°¡¼Ó
  • growth arrest line
    ¼ºÀåÁ¤Áö¼±
  • growth chart
    ¼ºÀå±â·ÏÁö
  • growth cone
    ¼ºÀå¿ø»Ô
  • growth curve
    ¼ºÀå°î¼±
  • growth cycle
    Áõ½ÄÁÖ±â
  • growth defect
    ¼ºÀå°áÇÔ
  • growth delay
    ¼ºÀåÁö¿¬
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • peak growth velocity
    Ãִ뼺Àå¼Óµµ
  • growth zone
    ¼ºÀ屸¿ª
  • factor
    ÀÎÀÚ, ¿äÀÎ, °è¼ö
  • activation factor
    Ȱ¼ºÀÎÀÚ
  • antiplatelet factor
    Ç×Ç÷¼ÒÆÇÀÎÀÚ
  • coagulation V factor
    Á¦5Ç÷¾×ÀÀ°íÀÎÀÚ
  • exclusion of confounding factor
    ±³¶õº¯¼ö¹èÁ¦
  • intrinsic factor
    ³»ÀÎÀÎÀÚ, ³»ÀÎÀÚ
  • platelet activating factor
    Ç÷¼ÒÆÇȰ¼ºÀÎÀÚ
  • precipitation factor
    ÃËÁø¿äÀÎ
  • predisposing factor
    ¼±Çà¿äÀÎ
  • prognostic factor
    ¿¹ÈÄÀÎÀÚ
  • psychological factor
    ½É¸®¿ä¼Ò
  • relaxing factor
    ÀÌ¿ÏÀÎÀÚ
  • resistance factor
    ³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • beta-adrenergic receptor kinase
    º£Å¸¾Æµå·¹³¯¸°¼º¼ö¿ëüÀλêÈ­È¿¼Ò
  • receptor binding
    ¼ö¿ëü°áÇÕ
  • receptor blocker
    ¼ö¿ëüÂ÷´ÜÁ¦
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • cholinergic receptor
    Äݸ°¼ö¿ëü
  • cold receptor
    ³Ã°¢¼ö¿ëü
  • complement receptor
    µµ¿òü¼ö¿ëü, º¸Ã¼¼ö¿ëü
  • corpuscular receptor
    ¼Òü¼ö¿ëü
  • receptor cell
    ¼ö¿ëü¼¼Æ÷
  • distance receptor
    (¢¡teleceptor) ¿ø°Ý¼ö¿ëü
  • dominant receptor
    ¿ì¼º¼ö¿ëü
  • early receptor potential
    Á¶±â½Ã°¢¼¼Æ÷ÀüÀ§
  • electromagnetic receptor
    ÀüÀÚ±â¼ö¿ëü
  • receptor destroying enzyme
    ¼ö¿ëüÆÄ±«È¿¼Ò
  • free receptor
    À¯¸®¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • growth hormone-releasing factor
    ¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
  • growth promoting factor
    ¼ºÀåÃËÁøÀÎÀÚ(à÷íþõµòäì×í­), ¹ßÀ°ÃËÁø¹°Áú(Û¡ëÀõµòäÚªòõ)
  • hematopoietic growth factor
    Á¶Ç÷¼ºÀåÀÎÀÚ
  • hepatocyte growth factor
    °£¼¼Æ÷¼ºÀåÀÎÀÚ
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
  • platelet-derived growth factor(PDGF)
    Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ
  • platelet-derived growth factor(pdgf)
    ÆÇ-À¯µµ¼ºÀåÀÎÀÚ(úìá³÷ù-ë¯Óôà÷íþì×í­)
  • F factor (fertility factor)
    FÀÎÀÚ, ¼öÅÂÀÎÀÚ
  • posterior auricular nerve of facial nerve
    ¾ó±¼½Å°æÀÇ µÚ±Ó¹ÙÄû½Å°æ, ¾È¸é ½Å°æ(äÔØüãêÌè)ÀÇ ÈÄÀ̰³½Å°æ.
  • posterior auricular nerve of facial nerve
    ¾ó°óº·wÀÇ µÚõ¤aÄû½Å°æ, ¾È¸é ½Å°æ(äÔØüãêÌè)ÀÇ ÈÄÀ̰³½Å°æ. µÚ
  • A1 receptor
    A1 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • A2 receptor
    A2 ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
  • CR1 => complement receptor 1
    º¸Ã¼¼ö¿ëü 1
  • CR2 => complement receptor 2
    º¸Ã¼¼ö¿ëü 2
  • CR3 => complement receptor 3
    º¸Ã¼¼ö¿ëü 3
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • growth factor
    ¼ºÀåÀÎÀÚ(à÷íþì×í­).
  • growth factor, B cell (BCGF)
    B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
  • growth hormone-releasing factor
    ¼ºÀåÈ£¸£¸óÀ¯¸®ÀÎÀÚ<--¹æÃâÀÎÀÚ>
  • growth promoting factor
    ¼ºÀåÃËÁøÀÎÀÚ(à÷íþõµòäì×í­), ¹ßÀ°ÃËÁø¹°Áú(Û¡ëÀõµòäÚªòõ)
  • hematopoietic growth factor
    Á¶Ç÷¼ºÀåÀÎÀÚ
  • hepatocyte growth factor
    °£¼¼Æ÷¼ºÀåÀÎÀÚ
  • insulin-like growth factor
    Àν¶¸°À¯»ç¼ºÀåÀÎÀÚ
  • macrophage,macrophage derived growth factor
    ´ë½Ä¼¼Æ÷±â¿ø ¼ºÀåÀÎÀÚ(¡­ÑÃê¹ à÷íþì×í­)
  • platelet-derived growth factor
    Ç÷¼ÒÆÇÀ¯·¡ Áõ½ÄÀÎÀÚ
  • platelet-derived growth factor(PDGF)
    Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ
  • platelet-derived growth factor(pdgf)
    ÆÇ-À¯µµ¼ºÀåÀÎÀÚ(úìá³÷ù-ë¯Óôà÷íþì×í­)
  • transforming growth factor
    Àüȯ¼ºÀåÀÎÀÚ
  • trasforming growth factor
    º¯È¯¼º ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    Ç÷°ü ³»ÇǼ¼Æ÷ ¼ºÀåÀÎÀÚ
  • vascular endothelial growth factor
    ¸Æ°ü³»ÇǼ¼Æ÷¼ºÀåÀÎÀÚ(ØæÎ·Ò®ù«á¬øàà÷íþì×í­)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lateral plantar nerve
    °¡Âʹ߹ٴڽŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÁ·Ã´½Å°æ
  • Lateral cutaneous nerve of forearm
    °¡ÂʾƷ¡ÆÈÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøÀü¿ÏÇǽŰæ
  • Lateral sural cutaneous nerve
    °¡ÂÊÀåµýÁöÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃøºñº¹ÇǽŰæ
  • Lateral ampullar nerve
    °¡ÂÊÆØ´ë½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÃøÆØ´ëºÎ½Å°æ
  • Subcostal nerve
    °¥ºñ¹Ø½Å°æ
    [¿¾ ¿ë¾î] ´ÁÇϽŰæ
  • Intercostobrachial nerve
    °¥ºñ»çÀÌÀ§ÆÈ½Å°æ
    [¿¾ ¿ë¾î] ´Á°£»ó¿Ï½Å°æ
  • Abducent nerve (VI)
    °«µ¹¸²½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÀü½Å°æ
  • Axillary nerve
    °Üµå¶û½Å°æ
    [¿¾ ¿ë¾î] ¾×¿Í½Å°æ
  • Nerve to tensor tympani
    °í¸·±äÀå±Ù½Å°æ
    [¿¾ ¿ë¾î] °í¸·Àå±Ù½Å°æ
  • Chorda tympani nerve
    °í½Ç²ö½Å°æ
    [¿¾ ¿ë¾î] °í»è½Å°æ
  • Tympanic nerve
    °í½Ç½Å°æ
    [¿¾ ¿ë¾î] °í½Ç½Å°æ
  • Perforating cutaneous nerve
    °üÅëÇǺνŰæ
    [¿¾ ¿ë¾î] °üÅëÇǽŰæ
  • Zygomatic nerve
    ±¤´ë½Å°æ
    [¿¾ ¿ë¾î] °ü°ñ½Å°æ
  • Communicating branches (with chorda tympani nerve)
    ±³Åë°¡Áö(°í½Ç²ö½Å°æ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö(°í»è½Å°æ°úÀÇ)
  • Communicating branch (with zygomatic nerve)
    ±³Åë°¡Áö(±¤´ë½Å°æ°úÀÇ)
    [¿¾ ¿ë¾î] ±³ÅëÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • dopamine adrenergic receptor
    "µµÆÄ¹Î ¾Æµå·¹³¯¸°ÀÛµ¿¼º(íÂÔÑàõ) ¼ö¿ëü(áôé»ô÷), (ÔÒ) adrenergic receptor"
  • Ehrlich's receptor theory
    ¿¡¸¦¸®È÷ ¼ö¿ëüÀÌ·Ð(áôé»ô÷×âÖå)
  • Fc receptor
    Fc ¼ö¿ëü(áôé»ô÷)
  • floating receptor model
    ºÎÀ¯ ¼ö¿ëü(Ý©ë´áôé»ô÷) ¸ðµ¨
  • glucocorticoid receptor
    ±Û·çÄÚÄÚ¸£Æ¼ÄÚÀÌµå ¼ö¿ëü(áôé»ô÷)
  • H1 receptor
    H1 ¼ö¿ëü(áôé»ô÷)
  • H2 receptor
    H2 ¼ö¿ëü(áôé»ô÷)
  • LDL receptor
    LDL ¼ö¿ëü(áôé»ô÷)
  • ligand-receptor internalization
    ¸®°£µå-¼ö¿ëü(áôé»ô÷) ³»ÀÔ(Ò®ìý)
  • mineralocorticoid receptor
    ±¤Áú(ÎÎòõ) ÄÚ¸£Æ¼ÄÚÀÌµå ¼ö¿ëü(áôé»ô÷)
  • mobile receptor model
    À̵¿¼ö¿ëü(ì¹ÔÑáôé»ô÷) ¸ðµ¨
  • muscarinic receptor
    ¹«½ºÄ«¸°¼ö¿ëü(áôéÄô÷)
  • nicotinic receptor
    ´ÏÄÚÆ¾¼ö¿ëü(â¥é»ô÷)
  • opiate receptor
    ¾ÆÆíÁ¦(ð¥) ¼ö¿ëü(áôé»ô÷)
  • opioid receptor
    ¾ÆÆí°è(ͧ) ¾à¹°¼ö¿ëü(å·Úªáôé»ô÷)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • risk factor
    À§Çè¿äÀÎ
  • turbo factor
    Åͺ¸ÀÎÀÚ
  • abducens nerve
    ¿ÜÇâ½Å°æ, ¿ÜÀü½Å°æ
  • accessory nerve
    ºÎ½Å°æ
  • acoustic nerve
    û½Å°æ
  • auditory nerve
    û½Å°æ
  • axillary nerve
    °Üµå¶û½Å°æ, ¾×¿Í½Å°æ
  • facial nerve
    ¾ó±¼½Å°æ, ¾È¸é½Å°æ
  • femoral nerve
    ´ëÅð½Å°æ
  • glossopharyngeal nerve
    ¼³ÀνŰæ
  • iliohypogastric nerve
    Àå°ñÇϺ¹½Å°æ
  • inferior laryngeal nerve
    ¾Æ·¡ÈĵνŰæ, ÇÏÈĵνŰæ
  • intercostal nerve
    ´Á°£½Å°æ
  • intermediate nerve
    Áß°£½Å°æ
  • jugular nerve
    °æÁ¤¸Æ½Å°æ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GRF gastrin-releasing factor; genetically related macrophage factor; gonadotropin-releasing factor; grow...
GF gastric fistula; gastric fluid; germ-free; glass factor; glomerular filtration; gluten-free; grandfa...
SGF sarcoma growth factor; skeletal growth factor
PAF paroxysmal atrial fibrillation; peroxisomal assembly factor; phosphodiesterase-activating factor; pl...
SF Sabin-Feldman [test]; safety factor; salt-free; scarlet fever; screen film; seminal fluid; serosal f...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
NGF Anti-nerve growth factor
beta NGF Beta nerve growth factor
NGF Beta-nerve growth factor
hNGF Human nerve growth factor
NGF Nerve Growth Factor
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • exclusively centrifugal growth
    ¹èŸÀû ¿ø½É ¼ºÀå
  • exponential growth
    Áö¼ö Áõ½Ä
  • exponential phase of growth
    ´ë¼ö Áõ½Ä±â, °¡¼Ó ¼ºÀå±â
  • horizontal growth
    ¼öÆò ¼ºÀå
  • human growth hormone
    ¼ºÀå È£¸£¸ó
    ¼ºÀåÀ» ÃËÁøÇÏ´Â ¹°ÁúÀ» ÃÑĪÇϸç, ƯÈ÷ ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÀ» ¸»ÇÑ´Ù.
  • neural growth
    ½Å°æ°èÇü ¼ºÀå
  • no growth
    ¹«¼ºÀå
  • nonbleeding growth
    ºñÃâÇ÷¼º ¼ºÀå
  • one step growth
    ÀÏ´Ü Áõ½Ä
  • papillomatous growth
    À¯µÎ¼º ¼ºÀå
    À¯µÎÁ¾°ú °°ÀÌ ´Ù¹ßÀûÀ¸·Î ÀϾ´Â ¼ºÀå.
  • polypoid growth
    Æú¸³ Áõ½Ä
  • prenatal facial growth
    Ãâ»ýÀüÀÇ ¾ó±¼ ¼ºÀå
  • proliferative growth
    Áõ½Ä¼º ¼ºÀå
  • retardation of growth
    ¼ºÀå Áö¿¬
  • somatic growth
    ½ÅüÇü ¼ºÀå, ü¼º ¼ºÀå
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
receptors, transforming growth factor beta Cell-surface proteins that bind transforming growth factor beta and trigger changes influencing the behaviour of cells. Two types of transforming growth factor receptors have been recognised. They differ in affinity for different members of the transforming growth factor beta family and in cellular mechanisms of action. Transforming growth factor alpha binds to the same receptors as epidermal growth factor (see receptors, epidermal growth factor-urogastrone).
(12 Dec 1998)
growth factor <biochemistry> A complex family of polypeptide hormones or biological factors that are produced by the body to control growth, division and maturation of blood cells by the bone marrow. They regulate the division and proliferation of cells and influence the growth rate of some cancers. These factors occur naturally but some can be synthesised using molecular biology techniques and are used clinically to stimulate normal white cell production following chemotherapy or bone marrow transplantation.
Examples include epidermal growth factor, platelet-derived growth factor, fibroblast growth factor. Insulin and somatomedin are also growth factors, the status of nerve growth factor is more uncertain. Perturbation of growth factor production or of the response to growth factor is important in neoplastic transformation.
(29 Sep 1997)
growth hormone-releasing factor <endocrinology> Peptide hormone related to the glucagon family, released from the pituitary, acts on the adenohypophysis to release growth hormone.
Synonym: somatoliberin, growth hormone-releasing factor.
(20 Sep 2002)
platelet-derived growth factor <growth factor> The major mitogen in serum for growth in culture of cells of connective tissue origin. It consists of 2 different but homologous polypeptides A and B (~30,000 D) linked by disulphide bonds. Believed to play a role in wound healing.
It is carried in the alpha-granules of platelets and is released when platelets adhere to traumatised tissues. Connective tissue cells near the traumatised region respond by initiating the process of replication.
The B chain is almost identical in sequence to p28sis, the transforming protein of simian sarcoma virus, that can transform only those cells that express receptors for platelet derived growth factor, suggesting that transformation is caused by autocrine stimulation. The receptor is a tyrosine kinase.
Acronym: PDGF
(12 Dec 1998)
sarcoma growth factor <growth factor> Polypeptide released by sarcoma cells that promotes the growth of cells by binding to a cell surface receptor, the sarcoma cell is therefore self sufficient and independent of normal growth control.
See: growth factors.
The name is no longer commonly used.
(18 Nov 1997)
heparin binding growth factor <growth factor> Acidic fibroblast growth factor (alpha FGF, HBGF 1) and basic FGF (beta FGF, HBGF 2) are the two founder members of a family of structurally related growth factors for mesodermal or neuroectodermal cells.
Synonym: heparin binding growth factor.
Acronym: FGF
(18 Nov 1997)
hepatocyte growth factor <growth factor> Polypeptide mitogen originally shown to cause cell division in hepatocytes.
In the liver, the main sources of hepatocyte growth factor are nonparenchymal cells. It is now clear that hepatocyte growth factor is a mitogen for a number of cell types and it is found in many cells outside the liver, including platelets.
Hepatocyte growth factor is synthesised as a single chain precursor that is proteolytically cleaved to give a heavy chain (70 kD) and a light chain (30 kD) linked by a single disulphide bond. It contains multiple copies of the kringle domain.
However, both the single chain precursor and the two chain forms of hepatocyte growth factor are biologically active and hepatocyte growth factor is generally isolated as a mixture of the two forms. Hepatocyte growth factor also alters cell motility and is now known to be identical to scatter factor.
Acronym: HGF
(18 Nov 1997)
pro-transforming growth factor-alpha processing protease <enzyme> Converts membrane-bound protgf-alpha to soluble tgf-alpha; mw 84 kD
Registry number: EC 3.4.21.-
Synonym: protgf-alpha converting enzyme, protgfalpha processing protease
(26 Jun 1999)
schwannoma derived growth factor <growth factor> A growth factor containing an EGF like domain, mitogenic for astrocytes, Schwann cells and fibroblasts.
(18 Nov 1997)
insulin like growth factor <growth factor> Insulin like growth factors I and II are polypeptides with considerable sequence similarity to insulin.
They are capable of eliciting the same biological responses, including mitogenesis in cell culture. On the cell surface, there are two types of insulin like growth factor receptor, one of which closely resembles the insulin receptor (which is also present).
Insulin like growth factor I = somatomedin A = somatomedin C
Insulin like growth factor II = MSA (Multiplication stimulating activity).
Insulin like growth factor 1 is released from the liver in response to growth hormone.
Acronym: IGF
(18 Nov 1997)
insulin-like growth-factor binding protein 1 One of the six homologous proteins that specifically bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions. The function of this protein is not completely defined. However, several studies demonstrate that it inhibits igf binding to cell surface receptors and thereby inhibits igf-mediated mitogenic and cell metabolic actions. (proc soc exp biol med 1993;204(1):4-29)
(12 Dec 1998)
insulin-like growth factor-binding protein 2 One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level.
(12 Dec 1998)
insulin-like growth factor binding protein 3 One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level.
(12 Dec 1998)
insulin like growth-factor-binding protein 4 One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level.
(12 Dec 1998)
insulin-like growth-factor-binding-protein 5 One of the six homologous soluble proteins that bind insulin-like growth factors (somatomedins) and modulate their mitogenic and metabolic actions at the cellular level.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • F factor
    FÀÎÀÚ;¿°¼ºÀÎÀÚ
  • R factor
    R ÀÎÀÚ(¼¼±ÕÀÇ ¾àÁ¦ ³»¼º ÀÎÀÚ)
  • Rh factor
    ¸®¼­½º ÀÎÀÚ(ÀûÇ÷±¸ ¼Ó¿¡ ÀÖ´Â ÀÀÇ÷¼Ò)
  • Rhesus factor(antigen)
    =RH FACTOR
  • coal-factor
    ¼®Åº Áß°³ »óÀÎ(µµ¸Å »óÀÎ)
  • common factor
    =COMMON DIVISOR
  • conversion factor
    (¹®ÀÇ.ÀÚ·áû±¸¿¡¼­ ½ÇÁ¦ »óǰ±¸¸ÅÀÎÀ¸·ÎÀÇ)ÀüȯÀ²
  • factor
    ¿ä¼Ò;¿äÀÎ;¿øÀÎ;Àμö;ÀÎÀÚ;°è¼ö;À²;´ë¸®»ó;µµ¸Å»ó;Á߸ÅÀÎ
  • factor analysis
    ÀÎÀÚ ºÐ¼®
  • factor cost
    ¿äÀÎ(¿ä¼­)ºñ¿ë
  • intrinsic factor
    (»ýÈ­)³»À缺ÀÎÀÚ
  • noise factor(figure)
    (ÁõÆø±â¿¡¼­ÀÇ)ÀâÀ½Áö¼ö
  • pp factor
    Ç× Æç¶ó±×¶ó ÀÎÀÚ(Æç¶ó±×¶ó ¿¹¹æ¿¡ ¾²´Â ´ÏÄÚÆ¾»ê,´ÏÄÚÆ¾»ê¸¶À̵å)
  • prime factor
    ¼ÒÀμö
  • releasing factor
    È£¸£¸ó ¹æÃâÀÎÀÚ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á